Stockreport

Caliway Selected to Present Preclinical Data on CBL-514 in Combination with GLP-1R Therapy at ECO 2026 [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF The presentation will be delivered by Arya M. Sharma, MD, Caliway's scientific advisor and a globally recognized authority in obesity medicine, who will discuss CBL-514 [Read more]